secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2024-11-25T23:59:59+00:00
Accession:  0000950170-24-130593
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma sets 2025 annual meeting for Jan 30, 2025; record date Dec 9, 2024
-----------------------------------------------------------------------------

- 2025 Annual Meeting to be held on January 30, 2025.
- Stockholders of record as of December 9, 2024 entitled to vote.
- Deadline for Rule 14a-8 shareholder proposals is December 10, 2024.
- Deadline for director nominations outside Rule 14a-8 (Sept 18, 2024) has passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000095017024130593/0000950170-24-130593-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000095017024130593/meip-20241122.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-130593

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer